Clinical Trial

VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease

Study acronym: VRAP-Heart
Recruiting
View on ClinicalTrials.gov →
Summary
This prospective, randomized-controlled multicenter study investigates whether virtual reality-assisted patient education in patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) can improve patient understanding and simulative orientation, thereby reducing postinterventional complications, resulting in significantly shorter length of stay.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-09-22; most recent amendment 2025-08-22.
Status change: Not Yet Recruiting → Recruiting 2022-12-22
Trial Details
NCT Number NCT05552352
Lead Sponsor Heinrich-Heine University, Duesseldorf
Collaborators: Edwards Lifesciences
Conditions Severe Aortic Valve Stenosis
Enrollment 300 participants
Start Date 2022-10-05
Primary Completion 2026-08-31 (estimated)
Study Completion 2027-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-08-28